Mercer Global Advisors
ELTX icon

Mercer Global Advisors’s Elicio Therapeutics ELTX Stock Holding History

Mercer Global Advisors’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Buy
+3,210
New +$32.2K ﹤0.01% 5034

Other funds holding ELTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Mercer Global Advisors's ELTX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Elicio Therapeutics (ELTX) in Q2 2026: 3,210 shares worth $12.6K. The stake represents ﹤0.01% of the portfolio and ranks #5034 among its holdings.

36 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

  • Mercer Global Advisors held 3,210 shares of Elicio Therapeutics worth $12.6K as of Q2 2026.
  • Elicio Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Elicio Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5034 holding.
  • 36 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.